Cyclerion Therapeutics, Inc.

... ...
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Pharmaceuticals Major
PFEPfizer Inc. 0.93%36.820.9%$1164.76m
JNJJohnson & Johnson 1.75%164.560.7%$1136.72m
LLYEli Lilly & Co. 1.89%206.171.1%$885.93m
ABBVAbbVie, Inc. 0.07%111.341.9%$726.45m
BMYBristol-Myers Squibb Co. 1.15%64.921.0%$672.97m
MRKMerck & Co., Inc. 0.01%81.190.7%$665.83m
AZNAstraZeneca Plc 1.50%53.341.2%$665.10m
ARCTArcturus Therapeutics Holdings, Inc. 4.34%66.540.0%$227.70m
GRTSGritstone Oncology, Inc. 9.20%27.900.0%$209.79m
VTRSViatris, Inc. 0.82%17.450.0%$194.31m
RPRXRoyalty Pharma Plc 1.69%51.270.2%$174.33m
NVSNovartis AG 0.25%97.120.2%$166.27m
GSKGlaxoSmithKline Plc 1.58%38.380.2%$149.01m
SNYSanofi 0.57%49.930.2%$129.20m
RGENRepligen Corp. 0.58%218.176.9%$82.15m

Company Profile

Cyclerion Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery, development, and commercialization of treatments for serious and orphan diseases, through the use of soluble guanylate cyclase (sGC) pharmacology. Its product pipeline includes several sGC stimulators, a small molecules that act synergistically with nitric oxide on sGC to boost production of cyclic guanosine monophosphate (cGMP). The company was founded on September 6, 2018 and is headquartered in Cambridge, MA.